March 28, 2017: REGENXBIO announced today that Olivier Danos was joining the company as CSO, a newly created position. Prior to joining REGENXBIO, Danos was senior VP, Cell and Gene Therapy at Cambridge, Biogen.
March 28, 2017: The CEO of Stada, which has faced activist pressure to overhaul its strategy was bugged, Germany's Manager Magazin said on Thursday.
March 28, 2017: Elon Musk, the visionary behind SpaceX and Tesla, has launched a new venture called Neuralink–a company that has hopes of bridging the line between science fiction and science fact by linking humans with artificial intelligence.
March 28, 2017: Shares of Tesaro are continuing to shoot up following the FDA’s approval of its ovarian cancer treatment, Zejula, formerly known as Niraparib, an oral, once-daily PARP inhibitor used as maintenance treatment.